Tvardi Therapeutics, Incorporated   Report issue

For profit Phase 1
Founded: Houston TX United States (2017)

Organization Overview

First Clinical Trial
2017
NCT03195699
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Tvardi Therapeutics, Incorporated